相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relevance of the Immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
Katherine I. Lin et al.
BLOOD (2009)
The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype
F. Dicker et al.
LEUKEMIA (2009)
A dual role of p53 in the control of autophagy
Ezgi Tasdemir et al.
AUTOPHAGY (2008)
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam et al.
BLOOD (2008)
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia:: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz et al.
BLOOD (2008)
A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL
O. G. Best et al.
LEUKEMIA (2008)
Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia
Wei Xu et al.
LEUKEMIA RESEARCH (2008)
Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma
Bruce D. Cheson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia
Thorsten Zenz et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
E. Van Den Neste et al.
LEUKEMIA (2007)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D. Catovsky et al.
LANCET (2007)
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: Results from the US Intergroup Phase III Trial E2997
Michael R. Grever et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab - incidence and predictors
Gautam Borthakur et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Dissecting p53-dependent apoptosis
J. E. Chipuk et al.
CELL DEATH AND DIFFERENTIATION (2006)
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
MJ Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia
A Raval et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia
AB Glassman et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma
JH Admirand et al.
MODERN PATHOLOGY (2004)
Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma
N Erol et al.
MELANOMA RESEARCH (2004)
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
FJ Giles et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
The importance of p53 location: nuclear or cytoplasmic zip code?
A O'Brate et al.
DRUG RESISTANCE UPDATES (2003)
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2002)
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells
G Lilling et al.
CANCER INVESTIGATION (2002)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
